These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36055578)
21. Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans. de Koning EJ; Höppener JW; Verbeek JS; Oosterwijk C; van Hulst KL; Baker CA; Lips CJ; Morris JF; Clark A Diabetes; 1994 May; 43(5):640-4. PubMed ID: 8168639 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro. Hull RL; Zraika S; Udayasankar J; Kisilevsky R; Szarek WA; Wight TN; Kahn SE Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1586-93. PubMed ID: 17804609 [TBL] [Abstract][Full Text] [Related]
23. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007 [TBL] [Abstract][Full Text] [Related]
24. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus. Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871 [TBL] [Abstract][Full Text] [Related]
25. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo. Mo XD; Gao LP; Wang QJ; Yin J; Jing YH Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142 [TBL] [Abstract][Full Text] [Related]
26. Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation. Zraika S; Aston-Mourney K; Marek P; Hull RL; Green PS; Udayasankar J; Subramanian SL; Raleigh DP; Kahn SE J Biol Chem; 2010 Jun; 285(24):18177-83. PubMed ID: 20400513 [TBL] [Abstract][Full Text] [Related]
27. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease. Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780 [TBL] [Abstract][Full Text] [Related]
28. Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture. Marzban L; Tomas A; Becker TC; Rosenberg L; Oberholzer J; Fraser PE; Halban PA; Verchere CB Diabetes; 2008 Nov; 57(11):3045-55. PubMed ID: 18694973 [TBL] [Abstract][Full Text] [Related]
29. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets. Meier DT; Entrup L; Templin AT; Hogan MF; Mellati M; Zraika S; Hull RL; Kahn SE Diabetologia; 2016 Oct; 59(10):2166-71. PubMed ID: 27393137 [TBL] [Abstract][Full Text] [Related]
30. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. O'Brien TD; Butler PC; Westermark P; Johnson KH Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454 [TBL] [Abstract][Full Text] [Related]
31. Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment. Montane J; de Pablo S; Castaño C; Rodríguez-Comas J; Cadavez L; Obach M; Visa M; Alcarraz-Vizán G; Sanchez-Martinez M; Nonell-Canals A; Parrizas M; Servitja JM; Novials A FASEB J; 2017 Dec; 31(12):5296-5306. PubMed ID: 28821639 [TBL] [Abstract][Full Text] [Related]
32. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Marzban L; Rhodes CJ; Steiner DF; Haataja L; Halban PA; Verchere CB Diabetes; 2006 Aug; 55(8):2192-201. PubMed ID: 16873681 [TBL] [Abstract][Full Text] [Related]